Subscribe To
Spero therapeutics shares rise on fda approval of pivotal complicated uti trial
Spero Therapeutics shares soared after the clinical-stage biopharmaceutical company announced that it has received special protocol approval from the ...
July 31, 2023, 3:42 pm
Spero therapeutics announces special protocol assessment agreement with fda for phase 3 pivot-po trial of tebipenem hbr
Phase 3 PIVOT-PO trial is expected to begin with First Patient, First Visit in 4Q 2023 Spero to receive $30 million development milestone payment from...
July 31, 2023, 12:05 pm
Spero therapeutics: the multi-asset pipeline could outpace the tebipenem hbr deal with gsk
Spero is eligible to receive up to $525 million in development and sales milestone payments as well as royalties on net product sales under the agreem...
July 5, 2023, 3:06 pm